|
시장보고서
상품코드
1522702
세계의 골접합 임플란트 시장 : 제품 유형, 재료, 골절 유형, 최종 사용자, 지역별 예측(-2032년)Global Osteosynthesis Implants Market Research Report Information By Product, By Material, By Fracture Type, By End User and by Region - Forecast till 2032 |
||||||
골접합 임플란트 시장 규모는 2023년 54억 달러, 2024년 56억 7,000만 달러에서 예측 기간 동안 6.11%의 연평균 복합 성장률(CAGR)을 나타내고, 2032년에는 96억 6,000만 달러 규모로 성장할 것으로 예상됩니다.
세계 골접합 임플란트 시장의 성장을 가속하는 두 가지 주요 요인은 전 세계 골절률 증가와 골다공증입니다. 골접합 임플란트와 관련된 몇 가지 도전 과제가 세계 시장 확대를 억제할 것으로 예상되지만, 현재 진행 중인 임상시험, 기술 혁신, 세계 고령화 등으로 인해 시장은 이익을 창출할 것으로 예상됩니다.
골량의 감소와 골절 증가는 골다공증의 특징이며, 골절 치료에 큰 문제를 가져옵니다. 골절은 골다공증 환자에게서 많이 발생하며, 특히 고관절, 척추, 손목과 같은 체중이 실리는 뼈에 많이 발생합니다. 골다공증 뼈의 골절은 손상된 뼈의 질이 감소하고 기계적 안정성이 감소하기 때문에 골다공증 뼈의 골절은 종종 특별한 문제를 일으킵니다. 골접합 임플란트는 기계적 지지력을 생성하고 골절 치유를 촉진하기 때문에 골다공증 환자의 골절 치료에 없어서는 안 될 필수 요소입니다.
골다공증 유병률이 전 세계적으로 증가함에 따라 뼈 접합 임플란트의 필요성이 증가하고 있으며, International Osteoporosis Foundation에 따르면 2019년에는 전 세계 5억 명의 남성과 여성이 골다공증의 영향을 받을 수 있으며, 3초마다 1명이 골다공증으로 인해 골절될 수 있다고 합니다. 골다공증으로 인해 골절이 발생할 수 있다고 합니다.
지역별 관점
북미는 2022년 39.76%의 점유율을 차지하며 연평균 6.33% 성장하여 2032년에는 39억 8,000만 달러에 달할 것으로 예측됩니다. 한편, 예측 기간 동안 유럽은 7.35%의 가장 높은 CAGR로 성장할 것으로 예상됩니다.
북미 골접합 임플란트 시장은 안정적인 발전이 예상되며 전망은 여전히 밝습니다. 이 시장은 높은 외상 및 스포츠 부상 발생률, 정형외과 수술 증가, 일류 의료 인프라 및 서비스 등의 요인에 의해 주도되고 있습니다.
유럽 시장은 현재 스포츠 부상 증가, 골다공증 유병률 증가, 외과적 개입의 이점에 대한 환자 인식 증가 등 다양한 요인으로 인해 빠르게 성장하고 있습니다.
아시아태평양은 2022년 9억 9,000만 달러에서 예측 기간 동안 5.13%의 연평균 복합 성장률(CAGR)을 나타낼 전망입니다. 전 세계 기타 지역은 2022년 7억 1,000만 달러에서 예측 기간 동안 2.76%의 연평균 복합 성장률(CAGR)을 나타낼 전망입니다.
세계 골접합 임플란트(Bone Joint Implant) 시장을 조사했으며, 시장 정의와 개요, 시장 성장에 영향을 미치는 요인과 시장 기회 분석, 시장 규모 추이 및 예측, 각종 부문별/지역별/주요 국가별 분석, 경쟁 환경, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.
목차
제1장 주요 요약
제2장 시장 개요
제3장 조사 방법
제4장 시장 역학
- 개요
- 성장 촉진요인
- 성장 억제요인
- 기회
제5장 시장 요인 분석
- Porter의 Five Forces 분석
- COVID-19가 세계의 골접합 임플란트 시장에 미치는 영향
제6장 세계의 골접합 임플란트 시장 : 제품별
- 개요
- 나사 및 플레이트
- 와이어 및 핀
- 골수내 로드 및 못
- 척추 고정 기기
제7장 세계의 골접합 임플란트 시장 : 재질별
- 개요
- 스테인리스 스틸
- 티타늄 및 티타늄 합금
- 생체흡수성 폴리머
- 기타
제8장 세계의 골접합 임플란트 시장 : 골절 유형별
- 개요
- 고관절 골절
- 무릎 골절
- 척추 골절
- 어깨 골절
- 기타
제9장 세계의 골접합 임플란트 시장 : 최종사용자별
- 개요
- 병원
- 정형외과 클리닉
- 외래수술센터(ASC)
제10장 세계의 골접합 임플란트 시장 : 지역별
- 개요
- 북미
- 유럽
- 아시아태평양
- 기타 지역
제11장 경쟁 구도
- 개요
- 시장 점유율 분석
- 경쟁 대시보드
- 공개 기업 주식 개요
- 비교 분석 : 주요 기업 재무 데이터
- 주요 전개와 성장 전략
제12장 기업 개요
- B. BRAUN SE
- JOHNSON & JOHNSON SERVICES, INC.
- CONMED CORPORATION
- GLOBUS MEDICAL, INC.
- ZIMMER BIOMET
- ARTHREX, INC.
- PRECISION SPINE INC.
- MEDARTIS AG
- DIETER MARQUARDT MEDIZINTECHNIK GMBH
- LEPU MEDICAL TECHNOLOGY(BEIJING) CO., LTD.
제13장 데이터 인용
LSH 24.08.08Global Osteosynthesis Implants Market Research Report Information By Product (Screws and Plates, Wires and Pins, Intramedullary Rods and Nails, and Spinal Fixation Devices), By Material (Stainless Steel, Titanium and Titanium Alloys, Bioabsorbable Polymers, and Others), By Fracture Type (Hip Fracture, Knee Fracture, Spine Fracture, Shoulder Fracture, and Others), By End User (Hospitals, Orthopaedic Clinics, and Ambulatory Surgical Centers) and by Region (North America, Europe, Asia-Pacific, and Rest of the World) - Forecast till 2032
Market Synopsis
The market for osteosynthesis implants was estimated to be worth USD 5.40 billion in 2023. According to projections, the market for osteosynthesis implants would increase at a compound annual growth rate (CAGR) of 6.11% from USD 5.67 billion in 2024 to USD 9.66 billion by 2032.
The two main drivers propelling the growth of the global osteosynthesis implant market are rising rates of fractures and osteoporosis worldwide. Nonetheless, it is anticipated that the difficulties related to osteosynthesis implants will limit the worldwide market's expansion. However, the market is expected to see profitable prospects due to ongoing clinical trials, increased technology breakthroughs, and an aging population globally.
Decreased bone mass and increased brittleness are the hallmarks of osteoporosis, which presents major problems for fracture care. Fractures are more common in people with osteoporosis, especially in weight-bearing bones like the hip, spine, and wrist. Because the quality of the damaged bone is lower and the mechanical stability is decreased, fractures in osteoporotic bones frequently pose special issues. Because they produce mechanical support and promote fracture healing, osteosynthesis implants are an essential part of the treatment of fractures in patients with osteoporosis.
The need for osteosynthesis implants is rising due to the rising prevalence of osteoporosis worldwide. For example, the International Osteoporosis Foundation stated in 2019 that 500 million men and women worldwide may be impacted by osteoporosis, and that a person breaks a bone owing to the condition every three seconds.
Insights on Market Segments
Based on products, screws and plates, wires and pins, intramedullary rods and nails, and spinal fixation devices, the worldwide osteosynthesis implants are segmented.
Based on material, the osteosynthesis implants market is segmented into categories such as bioabsorbable polymers, titanium and titanium alloys, stainless steel, and others.
Based on the kind of fracture, the osteosynthesis implants market has been divided into segments: hip, knee, spine, shoulder, and others.
Based on the end user, the osteosynthesis implants market has been divided into ambulatory surgical centers, orthopedic clinics, and hospitals.
Area Perspectives
The market is divided into four regions by the study: North America, Europe, Asia-Pacific, and the Rest of the World. Osteosynthesis implants in North America held the most market share of 39.76% in 2022 and are expected to grow at a compound annual growth rate (CAGR) of 6.33% to reach a projected USD 3.98 billion by 2032. Nonetheless, throughout the course of the projection period, Europe is expected to develop at the highest CAGR of 7.35%.
The market for osteosynthesis implants in North America is expected to develop steadily, and the outlook is still positive. The osteosynthesis implants market is driven by factors such as a high rate of trauma and sports injuries, an increase in orthopedic procedures, and first-rate healthcare infrastructure and services.
The market for osteosynthesis implants in Europe is currently experiencing rapid expansion due to a number of factors, including an increase in sports injuries, an increase in the prevalence of osteoporosis, and a growing patient awareness of the advantages of surgical intervention.
Osteosynthesis implants in Asia-Pacific were valued at USD 0.99 billion in 2022, and during the forecast period, the market is expected to increase at a compound annual growth rate (CAGR) of 5.13%. The Osteosynthesis Implants market for the Rest of the World was valued at USD 0.71 billion in 2022 and is anticipated to expand at a compound annual growth rate (CAGR) of 2.76% over the forecast period.
Principal Players
Medartis AG, Dieter Marquardt Medizintechnik GmbH, Lepu Medical Technology (Beijing)Co.,Ltd., Globus Medical, Inc., Zimmer Biomet, Arthrex, Inc., Precision Spine, Inc., Johnson & Johnson Services, Inc., CONMED Corporation, and Braun SE are some of the major companies in the osteosynthesis implant market.
TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
2 MARKET INTRODUCTION
- 2.1 DEFINITION
- 2.2 SCOPE OF THE STUDY
- 2.3 RESEARCH OBJECTIVE
- 2.4 MARKET STRUCTURE
3 RESEARCH METHODOLOGY
- 3.1 OVERVIEW
- 3.2 DATA FLOW
- 3.2.1 DATA MINING PROCESS
- 3.3 PURCHASED DATABASE:
- 3.4 SECONDARY SOURCES:
- 3.4.1 SECONDARY RESEARCH DATA FLOW:
- 3.5 PRIMARY RESEARCH:
- 3.5.1 PRIMARY RESEARCH DATA FLOW:
- 3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED
- 3.6 APPROACHES FOR MARKET SIZE ESTIMATION:
- 3.6.1 REVENUE ANALYSIS APPROACH
- 3.7 DATA FORECASTING
- 3.7.1 DATA FORECASTING TECHNIQUE
- 3.8 DATA MODELLING
- 3.8.1 MICROECONOMIC FACTOR ANALYSIS:
- 3.8.2 DATA MODELLING:
- 3.9 TEAMS AND ANALYST CONTRIBUTION
4 MARKET DYNAMICS
- 4.1 INTRODUCTION
- 4.2 DRIVERS
- 4.2.1 RISING INCIDENCES OF OSTEOPOROSIS ACROSS THE GLOBE
- 4.2.2 INCREASING INCIDENCE OF FRACTURES
- 4.3 RESTRAINTS
- 4.3.1 COMPLICATIONS ASSOCIATED WITH OSTEOSYNTHESIS IMPLANTS
- 4.4 OPPORTUNITY
- 4.4.1 GROWING TECHNOLOGICAL ADVANCMENTS AND ONGOING CLINICAL TRIALS
- 4.4.2 INCREASING ELDERLY POPULATION, WORLDWIDE
5 MARKET FACTOR ANALYSIS
- 5.1 PORTER'S FIVE FORCES MODEL
- 5.1.1 THREAT OF NEW ENTRANTS
- 5.1.2 BARGAINING POWER OF SUPPLIERS
- 5.1.3 THREAT OF SUBSTITUTES
- 5.1.4 BARGAINING POWER OF BUYERS
- 5.1.5 INTENSITY OF RIVALRY
- 5.2 IMPACT OF COVID-19 ON THE GLOBAL OSTEOSYNTHESIS IMPLANTS MARKET
6 GLOBAL OSTEOSYNTHESIS IMPLANTS MARKET, BY PRODUCT
- 6.1 OVERVIEW
- 6.2 SCREWS AND PLATES
- 6.3 WIRES AND PINS
- 6.4 INTRAMEDULLARY RODS AND NAILS
- 6.5 SPINAL FIXATION DEVICES
7 GLOBAL OSTEOSYNTHESIS IMPLANTS MARKET, BY MATERIAL
- 7.1 OVERVIEW
- 7.2 STAINLESS STEEL
- 7.3 TITANIUM AND TITANIUM ALLOYS
- 7.4 BIOABSORBABLE POLYMERS
- 7.5 OTHERS
8 GLOBAL OSTEOSYNTHESIS IMPLANTS MARKET, BY FRACTURE TYPE
- 8.1 OVERVIEW
- 8.2 HIP FRACTURE
- 8.3 KNEE FRACTURE
- 8.4 SPINE FRACTURE
- 8.5 SHOULDER FRACTURE
- 8.6 OTHERS
9 GLOBAL OSTEOSYNTHESIS IMPLANTS MARKET, BY END USER
- 9.1 OVERVIEW
- 9.2 HOSPITALS
- 9.3 ORTHOPAEDIC CLINICS
- 9.4 AMBULATORY SURGICAL CENTERS
10 GLOBAL OSTEOSYNTHESIS IMPLANTS MARKET, BY REGION
- 10.1 OVERVIEW
- 10.2 NORTH AMERICA
- 10.2.1 US
- 10.2.2 CANADA
- 10.3 EUROPE
- 10.3.1 GERMANY
- 10.3.2 FRANCE
- 10.3.3 UK
- 10.3.4 ITALY
- 10.3.5 SPAIN
- 10.3.6 REST OF EUROPE
- 10.4 ASIA-PACIFIC
- 10.4.1 CHINA
- 10.4.2 INDIA
- 10.4.3 JAPAN
- 10.4.4 SOUTH KOREA
- 10.4.5 AUSTRALIA
- 10.4.6 REST OF ASIA-PACIFIC
- 10.5 REST OF THE WORLD
- 10.5.1 MIDDLE EAST & AFRICA
- 10.5.2 LATIN AMERICA
11 COMPETITIVE LANDSCAPE
- 11.1 INTRODUCTION
- 11.2 MARKET SHARE ANALYSIS,
- 11.3 COMPETITOR DASHBOARD
- 11.4 PUBLIC PLAYERS STOCK SUMMARY
- 11.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
- 11.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
- 11.6.1 PRODUCT LAUNCH/ PRODUCT APPROVAL
- 11.6.2 MERGER
- 11.6.3 ACQUISITION
12 COMPANY PROFILES
- 12.1 B. BRAUN SE
- 12.1.1 COMPANY OVERVIEW
- 12.1.2 FINANCIAL OVERVIEW
- 12.1.3 PRODUCTS OFFERED
- 12.1.4 KEY DEVELOPMENTS
- 12.1.5 SWOT ANALYSIS
- 12.1.6 KEY STRATEGIES
- 12.2 JOHNSON & JOHNSON SERVICES, INC.
- 12.2.1 COMPANY OVERVIEW
- 12.2.2 FINANCIAL OVERVIEW
- 12.2.3 PRODUCTS OFFERED
- 12.2.4 KEY DEVELOPMENTS
- 12.2.5 SWOT ANALYSIS
- 12.2.6 KEY STRATEGIES
- 12.3 CONMED CORPORATION
- 12.3.1 COMPANY OVERVIEW
- 12.3.2 FINANCIAL OVERVIEW
- 12.3.3 PRODUCTS OFFERED
- 12.3.4 KEY DEVELOPMENTS
- 12.3.5 KEY STRATEGIES
- 12.4 GLOBUS MEDICAL, INC.
- 12.4.1 COMPANY OVERVIEW
- 12.4.2 FINANCIAL OVERVIEW
- 12.4.3 PRODUCTS OFFERED
- 12.4.4 KEY DEVELOPMENTS
- 12.4.5 SWOT ANALYSIS
- 12.4.6 KEY STRATEGIES
- 12.5 ZIMMER BIOMET
- 12.5.1 COMPANY OVERVIEW
- 12.5.2 FINANCIAL OVERVIEW
- 12.5.3 PRODUCTS OFFERED
- 12.5.4 KEY DEVELOPMENTS
- 12.5.5 SWOT ANALYSIS
- 12.5.6 KEY STRATEGIES
- 12.6 ARTHREX, INC.
- 12.6.1 COMPANY OVERVIEW
- 12.6.2 FINANCIAL OVERVIEW
- 12.6.3 PRODUCTS OFFERED
- 12.6.4 KEY DEVELOPMENTS
- 12.6.5 KEY STRATEGIES
- 12.7 PRECISION SPINE INC.
- 12.7.1 COMPANY OVERVIEW
- 12.7.2 FINANCIAL OVERVIEW
- 12.7.3 PRODUCTS OFFERED
- 12.7.4 KEY DEVELOPMENTS
- 12.7.5 KEY STRATEGIES
- 12.8 MEDARTIS AG
- 12.8.1 COMPANY OVERVIEW
- 12.8.2 FINANCIAL OVERVIEW
- 12.8.3 PRODUCTS OFFERED
- 12.8.4 KEY DEVELOPMENTS
- 12.8.5 KEY STRATEGIES
- 12.9 DIETER MARQUARDT MEDIZINTECHNIK GMBH
- 12.9.1 COMPANY OVERVIEW
- 12.9.2 FINANCIAL OVERVIEW
- 12.9.3 PRODUCTS OFFERED
- 12.9.4 KEY DEVELOPMENTS
- 12.9.5 KEY STRATEGIES
- 12.10 LEPU MEDICAL TECHNOLOGY(BEIJING)CO., LTD.
- 12.10.1 COMPANY OVERVIEW
- 12.10.2 FINANCIAL OVERVIEW
- 12.10.3 PRODUCTS OFFERED
- 12.10.4 KEY DEVELOPMENTS
- 12.10.5 SWOT ANALYSIS
- 12.10.6 KEY STRATEGIES
